Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02449369 · ClinicalTrials.gov registry record · Phase 4
Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee
A Phase 4 study, sponsored by AdventHealth.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT02449369 is a Phase 4 study that has completed, run by AdventHealth. The registered enrollment target is 180 participants.
The verdict
NCT02449369, a Phase 4 study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
This is a prospective, three-arm, randomized, open-label trial to determine if a new pain control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces average pain scores.
Interventions
- DRUG Preop acetaminophen IV
- DRUG Preop orphenadrine IV
- DRUG Postop oral oxycodone & acetaminophen
- DRUG Postop hydromorphone IV
- DRUG Postop oral orphenadrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02449369
The ClinicalTrials.gov registry entry for NCT02449369 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Preop acetaminophen IV is the first listed.
NCT02449369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02449369 about?
NCT02449369 is a clinical study titled "Intra-Venous Acetaminophen and Muscle Relaxants After Total Knee". This is a prospective, three-arm, randomized, open-label trial to determine if a new pain control protocol which includes regular dosing of intravenous acetaminophen and orphenadrine for 48 hours after total knee surgery reduces the need for opioid pain medication and reduces average pain scores.
What is the current status of trial NCT02449369?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2015-04. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02449369?
The interventions under investigation include: Preop acetaminophen IV (DRUG), Preop orphenadrine IV (DRUG), Postop oral oxycodone & acetaminophen (DRUG), Postop hydromorphone IV (DRUG), Postop oral orphenadrine (DRUG).
Who is sponsoring clinical trial NCT02449369?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.